Last reviewed · How we verify
NCT03455712
Impact of GWG Tool on Patient Knowledge
NA trial testing Gestational Weight Gain Card in Weight Gain in 140 participants. Completed in 7 September 2017.
1 November 2016
Quick facts
| Lead sponsor | MetroHealth Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 140 |
| Start date | 27 June 2016 |
| Primary completion | 1 November 2016 |
| Estimated completion | 7 September 2017 |
Drugs / interventions tested
- Gestational Weight Gain Card
Conditions studied
- Weight Gain — all drugs for Weight Gain →
- Pregnancy Related — all drugs for Pregnancy Related →
Sponsor
MetroHealth Medical Center
Who can join
18 and older, female only, with Weight Gain or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Women with singleton pregnancies at one outpatient clinic to be recruited for controlled clinical trial. Over eight weeks, women 15 0/7--22 6/7 weeks' with at least one prior prenatal visit to be enrolled in the control group. Women 6 0/7--14 6/7 weeks' to be enrolled in the intervention group at their first prenatal visit and to receive a pregnancy-specific gestational weight gain card. Women to be encouraged to record their weight at each prenatal care visit. All women to complete a GWG knowledge--based questionnaire at 15 0/7-22 6/7 weeks'.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03455712
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Weight Gain
Currently open trials in the same condition.
- NCT05652478 — Early Metabolic Effects of Antiretroviral Drugs in Healthy volUnteers: a Phase 2 Randomized Study · Phase 2 · recruiting
- NCT07325500 — Incretin Microdosing for Cardiometabolic Health in People With HIV · Phase 2 · recruiting
- NCT07190170 — Time Restricted Eating for WeIght LoSs MainTenance-2 · NA · recruiting
- NCT06511310 — Exercise, Brain Activity, and Weight Maintenance · NA · recruiting
- NCT04252547 — Effect of Kangaroo Care on Test Weighing · NA · recruiting
Other MetroHealth Medical Center trials
Trials by the same sponsor.
- NCT06734026 — Multimodal, Enriched Environment for Rehabilitation in Chronic Traumatic Brain Injury · NA · recruiting
- NCT06664892 — Ultrahypofractionated Whole Breast Radiation Following Chemotherapy · NA · not yet recruiting
- NCT06788795 — Effectiveness of a Wearable Hydration Device · Phase 2 · not yet recruiting
- NCT06836739 — At-Home Genital Nerve Stimulation for SCI Bowel · NA · recruiting
- NCT06113965 — Neural Operant Conditioning · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03455712 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by MetroHealth Medical Center
- Last refreshed: 25 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03455712.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing